Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2022-12-23 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights percentages, and the breakdown of these rights via shares and instruments, referencing Article 40, Section 1 of the WpHG (German Securities Trading Act). This content directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds. Although the document is disseminated via EQS News (which could suggest RPA or RNS), the specific content is a formal notification of a change in major holdings by JPMorgan Chase & Co. Therefore, the most precise classification is Major Shareholding Notification (MRQ).
2022-12-23 English
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG). It details changes in the percentage of voting rights held by T. Rowe Price Group, Inc. and its subsidiaries, crossing a threshold (from 3.01% to 5.26%). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing regulatory thresholds. The appropriate code is MRQ.
2022-12-23 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by JPMorgan Chase & Co., referencing specific German securities law articles (WpHG, Sec. 33, 34, 38). This directly corresponds to the definition of reporting changes in significant share ownership thresholds. The filing type 'Major Shareholding Notification' (MRQ) is the most appropriate classification for this type of disclosure.
2022-12-23 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections like 'Notification of Major Holdings', detailing changes in voting rights percentages (3.21%) and referencing German securities law (WpHG). This directly corresponds to the definition of a major shareholding notification, which in the provided schema is mapped to 'Major Shareholding Notification' (MRQ). Although the header mentions 'Voting Rights Announcements', the content structure aligns perfectly with a major holding disclosure.
2022-12-22 English
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG). It details changes in the percentage of voting rights held by a shareholder (Baillie Gifford & Co) in MorphoSys AG, crossing a threshold on December 16, 2022. This directly corresponds to the definition of reporting changes in significant share ownership levels, which maps to the Major Shareholding Notification category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the change in holding percentage, making MRQ more specific than DVA (Declaration of Voting Results) or RNS (General Regulatory Filing).
2022-12-22 English
Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023
Board/Management Information Classification · 1% confidence The document is a press release dated December 20, 2022, announcing the departure of the Chief Financial Officer (CFO), Sung Lee, in March 2023. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information' (MANG). It is not an earnings release (ER) as it focuses on personnel, not financial results highlights. It is not a full financial report (10-K or IR). It is a specific personnel announcement, making MANG the most accurate classification.
2022-12-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.